BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25853035)

  • 1. Study of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer.
    Xu Y; Jin Y; Liu L; Zhang X; Chen Y; Wei J
    FEBS Open Bio; 2015; 5():198-201. PubMed ID: 25853035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
    Ye L; Wang W; Chen C; Meng Q; Yu Y
    FEBS Open Bio; 2015; 5():809-12. PubMed ID: 26566475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma anti-BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer.
    Zhao H; Zhang X; Han Z; Wang Z; Wang Y
    FEBS Open Bio; 2018 May; 8(5):829-835. PubMed ID: 29744296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
    Wang J; Xu Y; Zhao H; Zhang X
    J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
    Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
    Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of circulating antibodies to ANXA1 in breast cancer.
    Huang Y; Zhang C; Chen C; Sun S; Zheng H; Wan S; Meng Q; Chen Y; Wei J
    Tumour Biol; 2015 Feb; 36(2):1233-6. PubMed ID: 25344217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating antibodies to p16 protein-derived peptides in breast cancer.
    Chen C; Huang Y; Zhang C; Liu T; Zheng HE; Wan S; Sun S; Meng Q; Chen Y; Wei J
    Mol Clin Oncol; 2015 May; 3(3):591-594. PubMed ID: 26137272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer.
    Xu S; Huangfu M; Jia X; Song X; Sun B; Lee KH; Liu L; Sun S
    Int J Clin Oncol; 2015 Oct; 20(5):982-8. PubMed ID: 25681877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further study of circulating IgG antibodies to CD25-derived peptide antigens in nonsmall cell lung cancer.
    Chen C; Wang W; Meng Q; Wu N; Wei J
    FEBS Open Bio; 2016 Mar; 6(3):211-5. PubMed ID: 27047749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
    Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
    Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer.
    Wang W; Guan S; Sun S; Jin Y; Lee KH; Chen Y; Wei J
    Tumour Biol; 2014 May; 35(5):4901-5. PubMed ID: 24453033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Novel Autoantibodies in Schizophrenia.
    Whelan R; St Clair D; Mustard CJ; Hallford P; Wei J
    Schizophr Bull; 2018 Oct; 44(6):1341-1349. PubMed ID: 29373732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma.
    Wang J; Xu Y; Wang Y; Zhang X; Zhang G
    Onco Targets Ther; 2019; 12():10487-10493. PubMed ID: 31819529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The usefulness of ELISA test for early serological detection of Trichinella spp. infection in pigs].
    Bień J
    Wiad Parazytol; 2007; 53(2):149-51. PubMed ID: 17912813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of combined determinations of Epstein-Barr virus antibodies for nasopharyngeal carcinoma assessed with receiver operating characteristic curve based on logistic regression].
    Cai YL; Zheng YM; Cheng JR; Li J; Mo YK; Zhong QY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):384-7. PubMed ID: 20387494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Plasma Antibodies Against CD25-Derived Peptide Antigens in Bladder Cancer.
    Du KL; Ji WT; Jiang QH; Wang Y
    Clin Lab; 2023 May; 69(5):. PubMed ID: 37145070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating anti-p16a IgG autoantibodies as a potential prognostic biomarker for non-small cell lung cancer.
    Zhao H; Zhang X; Han Z; Wang Y
    FEBS Open Bio; 2018 Nov; 8(11):1875-1881. PubMed ID: 30410866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hTERC and c-MYC genes in cervical epithelial exfoliated cells for cervical cancer screening.
    Li T; Tang L; Bian D; Jia Y; Huang X; Zhang X
    Int J Mol Med; 2014 May; 33(5):1289-97. PubMed ID: 24626956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.